Literature DB >> 3876764

Pharyngeal carriage rates of Haemophilus influenzae, type b and non-b, and prevalence of ampicillin-resistant Haemophilus influenzae among healthy day-care children in central Massachusetts.

W P Stephenson, G Doern, N Gantz, L Lipworth, K Chapin.   

Abstract

Pharyngeal swabs were obtained from 832 children less than 14 years of age attending day-care centers and family day-care homes in central Massachusetts during a seven-week period beginning March 1, 1982. Colonization rates for Haemophilus influenzae and for H. influenzae type b were 60.7% and 15.1%, respectively. Nonwhite children were more likely to be carriers of non-b H. influenzae than white children (62.9% vs. 47.8%, p less than 0.025). Children in day care for more than six months were more likely to be carriers of non-b H. influenzae than children in day care for six months or less (52.9% vs. 45.5%, p less than 0.05). There was no association between colonization rates and age, sex, type of day-care setting, number of siblings, number sharing a bedroom, history of otitis media, or history of antibiotic use. The prevalence of ampicillin-resistant H. influenzae was 6.3% among all children and 10.3% among carriers of H. influenzae. The prevalence of ampicillin resistance was significantly higher among type b carriers than among carriers of other types (15.1% vs. 8.3%, p less than 0.05). Children who had taken ampicillin or amoxicillin within the past three months were much more likely to be colonized with ampicillin-resistant H. influenzae than were children who had not taken these antibiotics (13.5% vs. 4.8%, p less than 0.0005). These observations have important clinical implications for the management of children with H. influenzae disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876764     DOI: 10.1093/oxfordjournals.aje.a114169

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

Review 1.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

2.  Prevalence of Haemophilus influenzae pharyngeal carriers in the school population of Catalonia. Working Group on invasive disease caused by Haemophilus influenzae.

Authors:  R Bou; A Domínguez; D Fontanals; I Sanfeliu; I Pons; J Renau; V Pineda; E Lobera; C Latorre; M Majó; L Salleras
Journal:  Eur J Epidemiol       Date:  2000-06       Impact factor: 8.082

3.  In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center.

Authors:  M J George; B Kitch; F W Henderson; P H Gilligan
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

4.  Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis.

Authors:  G Foulds; T J McBride; A K Knirsch; W J Rodriguez; W N Khan
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

5.  Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).

Authors:  J H Sportel; G H Koëter; R van Altena; A Löwenberg; W G Boersma
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

6.  Spread of non-typable multiply resistant Haemophilus influenzae in a South African hospital.

Authors:  C Heney; F Berkowitz; T Baise; M Cotton; M Khoosal; S Vally; R Barriere; J Saunders; H J Koornhof
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

7.  Nasopharyngeal carriage and antibiotic resistance of Haemophilus influenzae in healthy children.

Authors:  A J Howard; K T Dunkin; G W Millar
Journal:  Epidemiol Infect       Date:  1988-04       Impact factor: 2.451

8.  Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage.

Authors:  Joseph A Lewnard; Noga Givon-Lavi; Amit Huppert; Melinda M Pettigrew; Gili Regev-Yochay; Ron Dagan; Daniel M Weinberger
Journal:  J Infect Dis       Date:  2015-12-23       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.